This study reports, for the first time, a functional impact of DAPK2 and ATG5 loci in modulating CRC risk and provides new insights into the functional role of DAPK2 and ATG5 polymorphisms in disease pathogenesis. The gene discussed is DAPK2; the disease is colorectal carcinoma.